His lab is engaged on refining the alanine-scanning assay to a few key residues which will accurately distinguish amongst fibrils from neurodegenerative tauopathies. He envisions using this streamlined assay for postmortem neuropathological prognosis, And perhaps for blood screening of tauopathies.Their Tale laid the inspiration for what on earth i